AI Verdict
ABBV has stronger fundamentals based on our AI analysis.
ABBV vs COR Fundamental Comparison
| Metric | ABBV | COR |
|---|---|---|
| Revenue | $61.2B | $85.9B |
| Net Income | $4.2B | $559.6M |
| Net Margin | 6.9% | 0.7% |
| ROE | N/A | 29.3% |
| ROA | 3.2% | 0.7% |
| Current Ratio | 0.67x | 0.92x |
| Debt/Equity | N/A | 4.15x |
| EPS | $2.36 | $2.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs COR: Frequently Asked Questions
Is ABBV or COR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ABBV has stronger fundamentals. ABBV is rated HOLD (70% confidence) while COR is rated SELL (74% confidence). This is not investment advice.
How does ABBV compare to COR fundamentally?
AbbVie Inc. has ROE of N/A vs Cencora, Inc.'s 29.3%. Net margins are 6.9% vs 0.7% respectively.
Which stock pays higher dividends, ABBV or COR?
ABBV has a dividend yield of N/A or no dividend while COR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or COR for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while COR has SELL rating with 74% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs COR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs COR, the AI consensus favors ABBV based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.